These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20620437)

  • 1. Thrombopoietic agents in immune thrombocytopenia.
    Ghanima W; Bussel JB
    Semin Hematol; 2010 Jul; 47(3):258-65. PubMed ID: 20620437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura.
    Wang T; Wang Z; Yang R
    Crit Rev Oncol Hematol; 2011 Mar; 77(3):172-83. PubMed ID: 20378370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical findings with the first generation of thrombopoietic agents.
    Vadhan-Raj S
    Semin Hematol; 2010 Jul; 47(3):249-57. PubMed ID: 20620436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic immune thrombocytopenic purpura. New agents.
    Rodeghiero F; Ruggeri M
    Hamostaseologie; 2009 Jan; 29(1):76-9. PubMed ID: 19151853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of thrombopoietin in idiopathic thrombocytopenic purpura.
    von dem Borne A; Folman C; van den Oudenrijn S; Linthorst G; de Jong S; de Haas M
    Blood Rev; 2002 Mar; 16(1):57-9. PubMed ID: 11913997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis.
    Gernsheimer T
    Oncologist; 2009 Jan; 14(1):12-21. PubMed ID: 19144680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin factors.
    Wei P
    Cancer Treat Res; 2011; 157():75-93. PubMed ID: 21052951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
    Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
    Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
    Nugent D; McMillan R; Nichol JL; Slichter SJ
    Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and chemistry of thrombopoietic agents.
    Kuter DJ
    Semin Hematol; 2010 Jul; 47(3):243-8. PubMed ID: 20620435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New treatment methods for autoimmune thrombocytopenia].
    Koene HR
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2609-14. PubMed ID: 18161261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune thrombocytopenic purpura.
    Psaila B; Bussel JB
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):743-59, vii. PubMed ID: 17666288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics.
    Liebman HA; Pullarkat V
    Hematology Am Soc Hematol Educ Program; 2011; 2011():384-90. PubMed ID: 22160062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
    Gernsheimer T
    Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia.
    Levy B; Arnason JE; Bussel JB
    Curr Opin Oncol; 2008 Nov; 20(6):690-6. PubMed ID: 18841052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of cepharanthin in chronic idiopathic thrombocytopenic purpura.
    Sato T; Morita I; Fujita H; Ono M; Kimishima A; Tomiyama J; Murota S
    Platelets; 2001 May; 12(3):156-62. PubMed ID: 11304417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.